NICE in U-turn over Alexion's Strensiq

13:22 EDT 23 Sep 2016 | thePharmaLetter

A drug to treat a rare inherited bone disorder has been recommended for limited use by Britain’s pricing

Original Article: NICE in U-turn over Alexion's Strensiq


More From BioPortfolio on "NICE in U-turn over Alexion's Strensiq"

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...